Methylation & micronutrient substrate

What actually decides this outcome, in order of size

Monoamine synthesis runs on enzymes with obligate cofactors, and a cofactor gap is one of the few causes of low mood that is cheap to find and cheap to correct. It is also, in a well-fed adult, uncommon — and the honest ranking has to say both things. Ranked by how much of the outcome each factor owns:

1. Whether a deficiency is actually present, which is a measurement. Cobalamin and folate disorders have formal diagnostic guidance Devalia 2014, and the practical question of which folate measurement to use has been argued in the laboratory literature Farrell 2013. A supplement that corrects a deficiency you do not have is not a weak version of the intervention. It is a different act.
2. Everything upstream of the biochemistry, which is most of the variance and none of the shopping list. Sleep, alcohol, thyroid status and iron status all present as this complaint. The exclusion panel below is the highest-value part of this page and it is a blood draw rather than a purchase.
3. WHETHER MORE METHYL IS THE RIGHT DIRECTION, which is the sign question this page turns on. The methylation cycle is regulated, and pushing donors into a regulated cycle is not uniformly beneficial. The clearest published expression of the risk is a case report of possible SAMe-induced mania Abeysundera 2018. Anybody with a personal or family history of bipolar disorder is the reader for whom the direction on this page can reverse, and that is a conversation with a doctor before a purchase.
4. Genotype, which is real and much smaller than it is sold as. The common MTHFR variant was described as a candidate vascular risk factor Frosst 1995. Reduced enzyme activity is a biochemical fact; that a given person's low mood is caused by it is a separate claim that a genotype cannot establish. Homocysteine-lowering with B vitamins has been tested against cardiovascular endpoints Marti-Carvajal 2017 and examined by Mendelian randomization Yuan 2021, which is the most informative literature about what moving this cycle does and does not achieve.
5. Which form, because absorption and conversion differ. [6S]-5-methyltetrahydrofolate raised plasma folate more effectively than folic acid in a controlled comparison Prinz-Langenohl 2009, and the human enzyme that reduces folic acid is slow and variable Bailey 2009 — which is the mechanistic case for the reduced forms rather than a marketing one.
6. The ceiling, which exists and is not usually stated on the label. A tolerable upper intake level for folate has been set by a regulatory panel EFSA Panel on Nutrition 2023, and high sustained pyridoxine dosing has a documented neuropathy signal van Hunsel 2018. Both are the top of a curve on a page that is otherwise written as though there were no top.

The order to run these in, and what has to be true first

Measure, then correct what is measurably low, then stop. This is the one pathway on the site where the correct endpoint is often a normal result and no ongoing purchase.

1. The exclusion panel first, and it is the most valuable step here. Vitamin B12 with Methylmalonic Acid (MMA), Folate, RBC, Homocysteine, Ferritin, TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine) and Vitamin D (25-Hydroxy). Methylmalonic acid alongside B12 because the serum level alone misses functional deficiency, which is exactly the point the cobalamin guidance makes Devalia 2014; red cell rather than serum folate for the integration window Farrell 2013.
2. Methylcobalamin (B12) if B12 or methylmalonic acid says so. This is a correction, and the guidance on diagnosis and treatment is the document Devalia 2014. Neurological presentations need a clinician rather than a supplement decision.
3. Methylfolate (5-MTHF) or Folinic Acid if red cell folate is low. The reduced forms have a pharmacokinetic argument behind them Prinz-Langenohl 2009 Bailey 2009, and the upper level applies regardless of form EFSA Panel on Nutrition 2023. Correcting folate without checking B12 first can mask a B12 deficiency, which is the oldest error in this field and still the commonest.
4. Betaine Anhydrous (TMG) is the alternative methyl route and it has a direct human result. Betaine supplementation lowered plasma homocysteine in healthy men and women Steenge 2003, which makes it the cheapest way to move that number when the folate route is already saturated.
5. Vitamin B6 (P5P) is a cofactor for the decarboxylation steps and has the clearest ceiling on the page van Hunsel 2018. Dose it as a cofactor, not as a therapy.
6. SAM-e is the downstream product and is the most studied item here as a mood intervention. The Cochrane review is the reference point Galizia 2016, with a monotherapy trial Sarris 2020, an adjunctive trial in non-remittent depression Sarris 2018 and an earlier randomized comparison Mischoulon 2014. It is also the item with the mania report attached Abeysundera 2018, which is why it comes after the measurements rather than before them.
7. Methylation Support and Methylation Stack are fixed blends and a dose decision somebody else made, which is reasonable once the panel says which components are needed and unreasonable as a starting point. B-Complex is the same argument at lower doses.
8. Zinc, Magnesium, Iron and Omega-3 (Fish Oil) are the non-methyl micronutrients on this list, and Lithium Orotate is not a micronutrient at all — it is a low-dose version of a drug with a narrow therapeutic index, and it belongs in a clinical conversation rather than a stack.

What gets bought for this that cannot move it

The category that fails structurally is the methylation stack bought on a genotype. A direct-to-consumer report naming an MTHFR variant Frosst 1995 tells you about enzyme kinetics and nothing about whether your folate status is low, which is a measurement Farrell 2013. The clinical literature on moving this cycle pharmacologically has been assembled around cardiovascular endpoints Marti-Carvajal 2017 and genetic instruments Yuan 2021, and the results there are the most useful available guide to how much follows from lowering a homocysteine. Buying five products because of a genotype, without a folate or B12 result, is spending money on a hypothesis that a twenty-pound test would settle.

The direction failure is that more methyl is not uniformly better. This is a regulated cycle, and a case report of possible SAMe-induced mania Abeysundera 2018 is the published edge of what overshoot looks like. There is a documented upper level for folate EFSA Panel on Nutrition 2023 and a documented neuropathy risk for sustained high-dose pyridoxine van Hunsel 2018. A page that lists donors without listing ceilings has described one half of a dose-response curve.

The reader this page cannot help, and the boundary is worth stating plainly. Correcting a cofactor deficiency is not a treatment for a depressive illness, and the trial literature for the one item here with real mood data is modest and mixed Galizia 2016 Sarris 2018 Sarris 2020. If low mood is persistent, if it is getting worse, or if it is interfering with work or relationships, the right next step is a doctor rather than a supplement plan. And if the difficulty is thoughts of self-harm, that is a doctor or a crisis line today rather than any page, product or protocol on this site.

If the goal underneath is different, so is the page. Low mood with cold intolerance and weight change is Thyroid & metabolic rate. Low mood that is really exhaustion is Energy & fatigue. Low mood arriving in the second half of every cycle is Luteal phase & progesterone support. Low mood with a raised inflammatory marker is Inflammation & the cytokine route to low mood. And anything serotonergic taken alongside a prescribed serotonergic agent is the interaction that matters most across all of them.

How you would know it was working, on a real read-out and a real timescale

This page makes two predictions. The exclusion panel will move a real fraction of readers off this pathway entirely, because thyroid, iron and B12 problems present as this complaint Devalia 2014; and Homocysteine will fall on an adequate methyl-donor dose within twelve weeks whether or not mood changes, which is precisely what makes it a target-engagement measurement rather than an outcome Steenge 2003.

• Vitamin B12 with Methylmalonic Acid (MMA) and Folate, RBC at baseline and 12 weeks. Methylmalonic acid because it detects functional deficiency that a serum B12 misses Devalia 2014; red cell folate because it integrates over the life of a red cell rather than over yesterday's meal Farrell 2013.
• Homocysteine at baseline and 12 weeks. Twelve weeks because the folate pool it depends on turns over on that scale, and because a betaine or folate effect on this number is established in healthy adults Steenge 2003. Falling homocysteine says the biochemistry engaged; it does not say the mood will follow Marti-Carvajal 2017.
• TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine), Ferritin and Vitamin D (25-Hydroxy) once at the start. The three exclusions with cheap treatments that are not on this page.
• MTHFR, DNA Analysis once, and only if the result would change a decision. It is a one-time genotype and it does not need repeating; it tells you about enzyme activity Frosst 1995 rather than about status, which is what the folate measurement is for.
• A validated mood questionnaire, scored the same way, at baseline and every four weeks. Four-week intervals because the trials in this area report over weeks Sarris 2018 rather than days, and because a single bad week is not a trend.

What will fool you. Starting anything during the worst week of a bad month means the comparison is against a trough, and mood regresses toward the mean without help. A normal serum B12 does not exclude functional deficiency, which is the whole reason methylmalonic acid is on the list Devalia 2014. Correcting folate can normalize a blood count while a B12 deficiency continues, which is why the order matters. A lowered homocysteine is target engagement and not a clinical result Marti-Carvajal 2017 Yuan 2021. And a fixed blend that produces a good month tells you nothing about which of its eight components did it, which is an argument for correcting one measured deficit at a time.

Sources read for these sections

• Galizia I, Oldani L, et al. S-adenosyl methionine (SAMe) for depression in adults. Cochrane Database of Systematic Reviews 2016 · PMID 27727432
• Sarris J, Byrne GJ, et al. S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial. Psychopharmacology 2020 · PMID 31712971
• Sarris J, Murphy J, et al. Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: an 8-week double-blind, randomized, controlled trial. European Neuropsychopharmacology 2018 · PMID 30115553
• Mischoulon D, Price LH, et al. A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder. Journal of Clinical Psychiatry 2014 · PMID 24500245
• Abeysundera H, Gill R. Possible SAMe-induced mania. BMJ Case Reports 2018 · PMID 29950497
• Frosst P, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 1995 · PMID 7647779
• Prinz-Langenohl R, et al. [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C-->T polymorphism of methylenetetrahydrofolate reductase. British Journal of Pharmacology, 2009 · PMID 19917061
• Bailey SW, et al. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proceedings of the National Academy of Sciences 2009 · PMID 19706381
• EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA Panel). Scientific opinion on the tolerable upper intake level for folate. EFSA Journal 2023 · PMID 37965303
• Devalia V. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. British Journal of Haematology 2014;166(4):496-513 · PMID 24942828
• Yuan S, et al. Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study. BMC Medicine 2021 · PMID 33888102
• Marti-Carvajal AJ, et al. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database of Systematic Reviews 2017 · PMID 28816346
• Steenge GR, et al. Betaine supplementation lowers plasma homocysteine in healthy men and women. The Journal of Nutrition, 2003 · PMID 12730412
• van Hunsel F, et al. Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported Cases.. Drug Safety 2018 · PMID 29737502
• Farrell CJ, et al. Red cell or serum folate: what to do in clinical practice?. Clinical Chemistry and Laboratory Medicine 2013 · PMID 23449524